The HBS Precision Trials Challenge (www.precisiontrialschallenge.org) is a pioneering competition to generate ideas on how to bring diagnostics and therapies to market faster by reinventing the clinical trials process. From research labs to medicine cabinets, it takes at least 10 years and billions of dollars for one FDA approved drug. Precision medicine will bring faster innovation, targeted medicine and better treatment. Realizing the full potential of precision medicine will require a transformation of the clinical trials process. That is why the Health Care Initiative at Harvard Business School wants ideas from the science, patient, business and medical communities. Are you up for the challenge?
HBS wants ideas from people like you. As a participant, you will receive invaluable feedback from an online community of precision medicine influencers, executives, researchers, doctors and advocacy groups. A panel of judges will evaluate every application, seek the best ideas and select three finalists to share a $100,000 prize and receive national media exposure. The winner will be announced in April and will have the opportunity to present at the prestigious 2016 Personalized Medicine Conference to 600+ influencers. Applications must be submitted by March 13 and finalists will be announced in April.
Abby Ballou is the managing editor of MedTech Boston. She has a B.A. and M.Phil in English literature from NYU and the CUNY Graduate Center, respectively. When she isn't writing and editing for MedTech Boston, Abby enjoys reading, rock climbing, watching classic movies and listening to opera.
Send this to a friend